Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has asked Pfizer to withdraw valdecoxib (Bextra) from the market due to safety concerns.

Pharmacology Watch: The FDA Pulls Another COX-2 Inhibitor Off the Market